Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors.

Karaki, Soumaya; Anson, Marie; Tran, Thi; Giusti, Delphine; Blanc, Charlotte; Oudard, Stephane; Tartour, Eric

Karaki, Soumaya; Anson, Marie; Tran, Thi; Giusti, Delphine; Blanc, Charlotte; Oudard, Stephane; Tartour, Eric.

Afiliação

Karaki S; INSERM U970, Université Paris Descartes, Sorbonne Paris-Cité, 75015 Paris, France. soumaya.karaki@inserm.fr.
Anson M; INSERM U970, Université Paris Descartes, Sorbonne Paris-Cité, 75015 Paris, France. marie.anson@inserm.fr.
Tran T; INSERM U970, Université Paris Descartes, Sorbonne Paris-Cité, 75015 Paris, France. thi.tran@inserm.fr.
Giusti D; Hôpital Européen Georges Pompidou, AP-HP, Service d'Immunologie biologique, 75015 Paris, France. delphine.giusti@aphp.fr.
Blanc C; INSERM U970, Université Paris Descartes, Sorbonne Paris-Cité, 75015 Paris, France. Charlotte.blanc@gmail.com.
Oudard S; INSERM U970, Université Paris Descartes, Sorbonne Paris-Cité, 75015 Paris, France. stephane.oudard@aphp.fr.
Tartour E; Department of Oncology, Hôpital Européen Georges Pompidou, 75015 Paris, France. stephane.oudard@aphp.fr.

Vaccines (Basel) ; 4(4)2016 Nov 03.

Article em En | MEDLINE | ID: mdl-27827885

Palavras-chave

CD40; CTLA-4; OX40; PD-1; PD-L1; cancer vaccine; checkpoint inhibitors; combination therapy; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google